Tapentadol Tablet, Film Coated, Extended Release
Product Images NDC 0054-0937

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tapentadol (NDC 0054-0937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tapentadol 01)

Chemical structure of Tapentadol Hydrochloride showing its molecular arrangement with hydroxyl, amine groups, and hydrochloride salt.*

FDA Label Image

Chemical Structure (Tapentadol 02)

A line graph showing percent of patients improved versus percent improvement in pain from baseline at week 15 of treatment. It compares Tapentadol ER (dashed line) with placebo (solid line), illustrating higher patient improvement percentages for Tapentadol ER across various pain improvement thresholds.*

FDA Label Image

Chemical Structure (Tapentadol 03)

A line graph comparing percent of patients improved over percent improvement in pain from baseline at week 12 of a double-blind (DB) period. Two lines are shown: one solid line for Placebo and one dashed line for Tapentadol ER, indicating patient response rates over a range of pain improvement percentages.*

FDA Label Image

Chemical Structure (Tapentadol 04)

A line graph comparing percent improvement in pain at week 12 between patients taking Tapentadol ER and a placebo. The x-axis shows percent improvement from 0 to 100, and the y-axis shows the percent of patients improved from 0 to 100%. Two lines represent the Tapentadol ER group (dashed) and placebo group (solid), illustrating higher pain improvement percentages in the Tapentadol ER group throughout the range.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Tapentadol Extended Release Tablets 50 mg film-coated tablets, 60 count bottle label by Hikma Pharmaceuticals USA Inc. The label includes prescription use indication and cautions regarding tablet administration and legal transfer restrictions. It also provides storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Label for Tapentadol Extended Release Tablets 100 mg, an oral film-coated, extended release tablet. The bottle contains 60 tablets, labeled by Hikma Pharmaceuticals USA Inc. The label includes dosage strength, prescription-only status, and storage instructions, along with a barcode and federal caution statement.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Tapentadol 150 mg Extended Release Tablets label for oral use by Hikma Pharmaceuticals USA Inc. The label specifies the strength as 150 mg per tablet and indicates 60 tablets per package. Instructions note tablets should be swallowed whole and not chewed, crushed, or dissolved. The label includes storage directions and a caution about federal transfer restrictions.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Tapentadol Extended Release Tablets 200 mg label for a bottle containing 60 tablets. The label indicates oral use, with instructions to swallow tablets whole. It notes federal law restrictions on transfer, manufacturer and distributor information for Hikma Pharmaceuticals USA Inc., and storage conditions. A barcode and NDC number 0054-0939-21 are visible.*

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Label for Tapentadol extended release tablets, 250 mg strength, containing 60 film-coated tablets. The label notes the tablet is for oral use and includes instructions to swallow tablets whole without chewing, crushing, or dissolving. Manufactured by Hikma Pharmaceuticals USA Inc. The label also includes dosage and storage instructions, medication guide information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.